Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil vs isosorbide for embryo transfer outcome in recurrent implantation failure
IRCT20110301005942N8Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sildenafil and isosorbide dinitrate in female infertility and Recurrent Implantation Failure (RIF) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Embryo implantation outcome. Started Aug 2021; status: completed.
02
Drugs
sildenafilisosorbide dinitrate
03
Conditions
female infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20110301005942N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110301005942N8.